ArticleTransboundary and emerging diseases2026
Serosurveillance and Postvaccination Seromonitoring of Peste Des Petits Ruminants in Small Ruminants in Central Gondar Zone, Northwest Ethiopia.
Article in Transboundary and emerging diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Serosurveillance and Postvaccination Seromonitoring of Peste Des Petits Ruminants in Small Ruminants in Central Gondar Zone, Northwest Ethiopia.Transboundary and emerging diseases · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Peste des petits ruminants (PPR) is a highly contagious transboundary viral disease of small ruminants caused by the PPR virus (PPRV). Despite Ethiopia's goal of eradicating PPR by 2027 through a risk-based vaccination strategy, the disease remains endemic, with 554 outbreaks reported nationwide. This cross-sectional study was conducted in the North Gondar Zone, Ethiopia, between June 2024 and February 2025 to evaluate antibody responses in vaccinated small ruminants and estimate PPRV seroprevalence in unvaccinated flocks. A multistage cluster sampling design was used to select the study sites, while individual animals were selected using a haphazard sampling approach to approximate random sampling. A total of 600 serum samples were collected, including 300 from vaccinated and 300 from unvaccinated small ruminants; samples from vaccinated animals were obtained ~28 days postvaccination. All samples were tested for anti-PPRV antibodies using competitive enzyme-linked immunosorbent assay (c-ELISA). Overall individual-level seropositivity in the vaccinated population was 75%, comprising 75.73% in sheep and 72.1% in goats, serving as a proxy measure of flock immunity. In unvaccinated animals, PPRV seroprevalence was 14.33% (95% confidence interval [CI]: 10.6%-18.82%). Multivariable logistic regression identified age and flock size as the main risk factors influencing seropositivity. Adult animals were 2.89 times as likely to be seropositive as young animals (95% CI: 1.17-7.15; p = 0.022), and animals in medium-sized flocks were more likely to test positive than those in small flocks (AOR = 2.26; 95% CI: 1.11-4.63; p = 0.026). No significant differences were observed across districts, species, sex, production systems, newly introduced animals, or animal movement (p > 0.05). The observed seropositivity was slightly below the commonly used 80% population immunity target associated with reducing transmission under the PPR eradication framework. The detection of PPRV antibodies in unvaccinated animals indicates previous exposure to PPRV and highlights the need for strengthened surveillance to assess whether active virus circulation persists in the area. To achieve effective control and eventual eradication of PPR, intensified vaccination programs combined with active surveillance are needed. Furthermore, refining vaccination strategies in alignment with global and national eradication plans is essential to establish PPR-free zones in these districts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.